Pomdoctor Receives Nasdaq Delisting Determination
MT newswire2026/10/09 20:5204:52 PM EDT, 10/09/2026 (MT Newswires) -- Pomdoctor Limited (POM) said it received a Nasdaq staff determination letter Tuesday stating that its American depositary shares are subject to delisting for failing to meet the minimum bid price requirement. The ADSs closed below $1.00 for 30 consecutive business days, from Aug. 24 through Oct. 5. Pomdoctor is not eligible for a compliance period because it effected a 1-for-18 reverse stock split on June 22, within the prior year. The company intends to request a hearing before a Nasdaq hearings panel by the Oct. 13 deadline. A timely request will stay the trading suspension, which would otherwise take effect Oct. 15, and the filing of a delisting notice pending the panel's decision.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI hot money floods upstream miners: Tech giants want to "invest" in Anglo American, BHP, and other mining companies to secure copper supply
Technology companies are seeking to acquire stakes in mining firms to secure metal supplies, with both Anglo American and BHP engaging in discussions with YunShang.

Pyth Network Price Prediction: Can PYTH’s Breakout Reach $1.15?
